Chemotherapy in stage-IV NSCLC-Reference-Cited by-同舟云学术

Chemotherapy in stage-IV NSCLC

Published:2004-08 Issue: Volume:45 Page:S217-S222
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Reck Martin,Gatzemeier Ulrich

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference39 articles.

1. Surgery in non-small cell lung cancer;Ginsberg,1995

2. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trials;Br Med J,1995

3. The Big Lung Trial (BLT): determining the value of cisplatin-based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting;Stephens,2002

4. Comparison of four chemotherapy regimens for advanced non-small cell lung cancer;Schiller;N Engl J Med,2002

5. Randomized phase III trial of Paclitaxel plus Carboplatin versus Vinorelbine plus cisplatin in the treatment of patients with advanced non-small cell lung cancer: a Southwest Oncology Group trial;Kelly;J Clin Oncol,2001

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of real-world data to investigate evolving treatment sequencing patterns in advanced non-small cell lung cancers and their impact on survival;Journal of Thoracic Disease;2023-05

2. Effect of MMP11 Gene on Diagnosis and Prognosis of Lung Adenocarcinoma;World Journal of Cancer Research;2023

3. Tepotinib hydrochloride for the treatment of non-small cell lung cancer;Drugs of Today;2021

4. Bayesian Two-Stage Biomarker-Based Adaptive Design for Targeted Therapy Development;Statistics in Biosciences;2014-12-04

5. Antitumor activity of lobaplatin alone or in combination with antitubulin agents in non-small-cell lung cancer;Anti-Cancer Drugs;2012-08